406 related articles for article (PubMed ID: 15644401)
1. Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma.
Amar L; Servais A; Gimenez-Roqueplo AP; Zinzindohoue F; Chatellier G; Plouin PF
J Clin Endocrinol Metab; 2005 Apr; 90(4):2110-6. PubMed ID: 15644401
[TBL] [Abstract][Full Text] [Related]
2. Changes in urinary total metanephrine excretion in recurrent and malignant pheochromocytomas and secreting paragangliomas.
Amar L; Peyrard S; Rossignol P; Zinzindohoue F; Gimenez-Roqueplo AP; Plouin PF
Ann N Y Acad Sci; 2006 Aug; 1073():383-91. PubMed ID: 17102107
[TBL] [Abstract][Full Text] [Related]
3. Analysis of pheochromocytomas / paragangliomas from Eastern Slovakia.
Felsoci M; Lazurova I; Wagnerova H; Svajdler M
Neoplasma; 2013; 60(4):452-8. PubMed ID: 23581419
[TBL] [Abstract][Full Text] [Related]
4. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.
Benn DE; Gimenez-Roqueplo AP; Reilly JR; Bertherat J; Burgess J; Byth K; Croxson M; Dahia PL; Elston M; Gimm O; Henley D; Herman P; Murday V; Niccoli-Sire P; Pasieka JL; Rohmer V; Tucker K; Jeunemaitre X; Marsh DJ; Plouin PF; Robinson BG
J Clin Endocrinol Metab; 2006 Mar; 91(3):827-36. PubMed ID: 16317055
[TBL] [Abstract][Full Text] [Related]
5. Pheochromocytomas and secreting paragangliomas.
Plouin PF; Gimenez-Roqueplo AP
Orphanet J Rare Dis; 2006 Dec; 1():49. PubMed ID: 17156452
[TBL] [Abstract][Full Text] [Related]
6. Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas.
Amar L; Baudin E; Burnichon N; Peyrard S; Silvera S; Bertherat J; Bertagna X; Schlumberger M; Jeunemaitre X; Gimenez-Roqueplo AP; Plouin PF
J Clin Endocrinol Metab; 2007 Oct; 92(10):3822-8. PubMed ID: 17652212
[TBL] [Abstract][Full Text] [Related]
7. Predictors of recurrence of pheochromocytoma and paraganglioma: a multicenter study in Piedmont, Italy.
Parasiliti-Caprino M; Lucatello B; Lopez C; Burrello J; Maletta F; Mistrangelo M; Migliore E; Tassone F; La Grotta A; Pia A; Reimondo G; Giordano R; Giraudo G; Piovesan A; Ciccone G; Deandreis D; Limone P; Orlandi F; Borretta G; Volante M; Mulatero P; Papotti M; Aimaretti G; Terzolo M; Morino M; Pasini B; Veglio F; Ghigo E; Arvat E; Maccario M
Hypertens Res; 2020 Jun; 43(6):500-510. PubMed ID: 31586159
[TBL] [Abstract][Full Text] [Related]
8. Genetics of pheochromocytoma and paraganglioma in Spanish patients.
Cascón A; Pita G; Burnichon N; Landa I; López-Jiménez E; Montero-Conde C; Leskelä S; Leandro-García LJ; Letón R; Rodríguez-Antona C; Díaz JA; López-Vidriero E; González-Neira A; Velasco A; Matias-Guiu X; Gimenez-Roqueplo AP; Robledo M
J Clin Endocrinol Metab; 2009 May; 94(5):1701-5. PubMed ID: 19258401
[TBL] [Abstract][Full Text] [Related]
9. DNA flow cytometry in pheochromocytoma and paraganglioma.
Jung WH; Yang WI; Park C; Choi IJ
Yonsei Med J; 1992 Sep; 33(3):249-57. PubMed ID: 1292249
[TBL] [Abstract][Full Text] [Related]
10. Frequent EPAS1/HIF2α exons 9 and 12 mutations in non-familial pheochromocytoma.
Welander J; Andreasson A; Brauckhoff M; Bäckdahl M; Larsson C; Gimm O; Söderkvist P
Endocr Relat Cancer; 2014 Jun; 21(3):495-504. PubMed ID: 24741025
[TBL] [Abstract][Full Text] [Related]
11. Paragangliomas: etiology, presentation, and management.
Joynt KE; Moslehi JJ; Baughman KL
Cardiol Rev; 2009; 17(4):159-64. PubMed ID: 19525677
[TBL] [Abstract][Full Text] [Related]
12. [Pheochromocytoma and paraganglioma: basics for the general practitioner].
Loosli N; Köhler BB; Pechère-Bertschi A; Karenovics W; Triponex F
Rev Med Suisse; 2014 Sep; 10(441):1650-2, 1654-5. PubMed ID: 25322623
[TBL] [Abstract][Full Text] [Related]
13. Familial pheochromocytomas and paragangliomas.
King KS; Pacak K
Mol Cell Endocrinol; 2014 Apr; 386(1-2):92-100. PubMed ID: 23933153
[TBL] [Abstract][Full Text] [Related]
14. [Pheochromocytomas as adrenal gland incidentalomas].
Cerović S; Cizmić M; Milović N; Ajdinović B; Brajusković G
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():47-51. PubMed ID: 12584998
[TBL] [Abstract][Full Text] [Related]
15. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators.
Ayala-Ramirez M; Feng L; Johnson MM; Ejaz S; Habra MA; Rich T; Busaidy N; Cote GJ; Perrier N; Phan A; Patel S; Waguespack S; Jimenez C
J Clin Endocrinol Metab; 2011 Mar; 96(3):717-25. PubMed ID: 21190975
[TBL] [Abstract][Full Text] [Related]
16. Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma.
Christensen TT; Frystyk J; Poulsen PL
Scand J Clin Lab Invest; 2011 Dec; 71(8):695-700. PubMed ID: 22023043
[TBL] [Abstract][Full Text] [Related]
17. Long-term postoperative follow-up in patients with apparently benign pheochromocytoma and paraganglioma.
Amar L; Fassnacht M; Gimenez-Roqueplo AP; Januszewicz A; Prejbisz A; Timmers H; Plouin PF
Horm Metab Res; 2012 May; 44(5):385-9. PubMed ID: 22351478
[TBL] [Abstract][Full Text] [Related]
18. Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing.
Crona J; Delgado Verdugo A; Maharjan R; Stålberg P; Granberg D; Hellman P; Björklund P
J Clin Endocrinol Metab; 2013 Jul; 98(7):E1266-71. PubMed ID: 23640968
[TBL] [Abstract][Full Text] [Related]
19. Extra-adrenal and adrenal pheochromocytomas associated with a germline SDHC mutation.
Peczkowska M; Cascon A; Prejbisz A; Kubaszek A; Cwikła BJ; Furmanek M; Erlic Z; Eng C; Januszewicz A; Neumann HP
Nat Clin Pract Endocrinol Metab; 2008 Feb; 4(2):111-5. PubMed ID: 18212813
[TBL] [Abstract][Full Text] [Related]
20. Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center.
Pham TH; Moir C; Thompson GB; Zarroug AE; Hamner CE; Farley D; van Heerden J; Lteif AN; Young WF
Pediatrics; 2006 Sep; 118(3):1109-17. PubMed ID: 16951005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
